Symbol Lookup

Friday August 26, 2016 9:36 AM ET. Data delayed 15 minutes.
0.00 (0.00%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Guided Therapeutics Reports Second Quarter 2016 Financial Results; Year to Date Revenue Up 71% Over Same Period Last Year
4:05PM ET on Wednesday Aug 17, 2016 by Business Wire

--100th LuViva(R) Advanced Cervical Scan shipped in Q2

--60,000 Cervical Guides sold to date

--Continued growth in the Latin America and Eastern Europe

--Regulatory approval granted in Costa Rica

--License deal for C...

Smart Lighting Technology Emerging as Leading Segment of Multi Billion Dollar Clean Useable Energy Industry
9:00AM ET on Tuesday Aug 16, 2016 by PR Newswire

The demand for energy-efficient solutions and products that included LED technology has received significant attention recently from companies, utilities and consumers looking to reduce their energy consumption use. As clean energy continues t...

Company Information

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The Company's technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The Company focuses on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage. Its product, in addition to detecting the structural changes attributed to cervical cancer, is also detects the biochemical changes that precede the development of visual lesions. LuViva consists of three components: Touch screen monitor, Hand Held Unit (HHU) and the Wheeled Base.


Headquarters5835 Peachtree Cors E Ste D
NORCROSS, GA, United States 30092-3413


Independent Chairman and DirectorMichael James
Chief Executive Officer, Acting Chief Financial Officer, President and DirectorGene Cartwright
Senior Vice President - EngineeringRichard Fowler
Independent DirectorJohn Imhoff
Independent DirectorJonathan Niloff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$215.5KBeta0.25
Revenue (TTM)$743.0KEPS$-3.73
Shares Out.153.9MBook Value$-2.35
Guided Therapeutics Inc does not pay a dividend.P/E--
Price/Sales (TTM)0.3
P/Cash Flow (TTM)--
Operating Margin-728.13%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample